July 19, 2022 12:49 PM EDT
Pharma
Marketing

Mar­ket­ingRx roundup: Pfiz­er de­buts new ‘Menopause’ pod­cast sea­son; Pfiz­er, Mod­er­na nab top spots on in­no­va­tion list

Beth Snyder Bulik

Senior Editor

The Pfiz­er-spon­sored third pod­cast sea­son of “Menopause Un­mut­ed” de­buted re­cent­ly with a new fo­cus. The can­did se­ries, be­gun in 2020, is led by Mary Jane …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Am­gen obe­si­ty shot shows 20% weight loss, but dos­ing ques­tions hang over read­out

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

The Biden ad­min­is­tra­tion wants Medicare and Med­ic­aid to cov­er GLP-1s. Will the Trump White House al­low it?

Up­dat­ed: Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

Food al­ler­gy biotech Al­ladapt clos­es af­ter Phase 3 talks with FDA

Soleno’s rare pe­di­atric dis­ease drug faces PDU­FA de­lay by three months

A service from the Financial Times